CLCGCrossmark Large Cap Growth ETF

Grow my moneyNewRanked #2,194 of 2,960 in this goal

Long-term capital appreciation.

By Crossmark Inc · Launched 2025

Annual Cost

0.50%

#2,576 of 5,562 · average

Fund Size

$29M

#4,094 of 5,562 · small

Return (1Y)Goal

N/A

Track Record

11 months

#4,598 of 5,562 · young

Performance

Total-return NAV · USD

Growth of $10,000

$11,513+15.1%

Total-return NAV, USD. Net of fund fees, before tax.

Classification

How Beacon categorizes this fund

Asset class

Equity

Region

North america

Cap

Large

Strategy

Active selection

Factor

Growth

Focus

Cannabis

What it actually holds

By weight

Concentration

Top 10 holdings = 66.0% of fundconcentrated

NVIDIA CORP

14.8%

APPLE INC

12.8%

ALPHABET INC-CL A

9.1%

MICROSOFT CORP

8.4%

BROADCOM INC

6.4%

VISA INC-CLASS A SHARES

3.4%

MASTERCARD INC - A

3.3%

ARISTA NETWORKS INC

2.7%

GILEAD SCIENCES INC

2.6%

MCKESSON CORP

2.5%

Asset allocation

Stocks

99.9%

Cash

0.1%

By sector

Technology

58.7%

Financial Services

12.7%

Communication

12.3%

Consumer Cyclical

7.9%

Healthcare

5.4%

Industrials

2.0%

Basic Materials

1.0%

Risk profile

Last 12 months · Sharpe & Sortino need 3+ years

Volatility (1Y)

N/A

Max drawdown

-16.3%Moderate

Worst peak-to-trough loss

Sharpe (3Y)

Unavailable

Needs 3+ years of history

Sortino (3Y)

Not yet

Needs 3+ years of history

Where to buy

Listing

Exchange: NYSE Arca

Full fund details

Objective: Long-term capital appreciation.
Strategy: Actively manages a portfolio of large-cap growth securities, investing at least 80% of net assets in large-cap growth companies. Uses quantitative techniques, fundamental analysis, and risk management to select securities, focusing on those with potential for earnings or revenue growth. The Fund may invest in small- and mid-cap companies and other investment vehicles. It applies values-based screening to avoid companies involved in alcohol, tobacco, gambling, abortion, adult entertainment, and cannabis, divesting from any holdings that do not meet these criteria.
Inception date: July 22, 2025
Fund family: Crossmark Inc